Balchem is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in August. At present, Balchem's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 99.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30.2 M. Key indicators impacting Balchem's financial strength include:
Investors should never underestimate Balchem's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Balchem's cash flow, debt, and profitability to make informed and accurate decisions about investing in Balchem.
Understanding current and past Balchem Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Balchem's financial statements are interrelated, with each one affecting the others. For example, an increase in Balchem's assets may result in an increase in income on the income statement.
Please note, the presentation of Balchem's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Balchem's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Balchem's management manipulating its earnings.
Balchem Stock Summary
Balchem competes with Sensient Technologies, Innospec, Minerals Technologies, Oil Dri, and H B. Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York. Balchem Cp operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1382 people.
Comparative valuation techniques use various fundamental indicators to help in determining Balchem's current stock value. Our valuation model uses many indicators to compare Balchem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Balchem competition to find correlations between indicators driving Balchem's intrinsic value. More Info.
Balchem is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Balchem is roughly 1.58 . At present, Balchem's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balchem's earnings, one of the primary drivers of an investment's value.
Balchem's Earnings Breakdown by Geography
Balchem Systematic Risk
Balchem's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Balchem volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was nine with a total number of output elements of fifty-two. The Beta measures systematic risk based on how returns on Balchem correlated with the market. If Beta is less than 0 Balchem generally moves in the opposite direction as compared to the market. If Balchem Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Balchem is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Balchem is generally in the same direction as the market. If Beta > 1 Balchem moves generally in the same direction as, but more than the movement of the benchmark.
Balchem Thematic Clasifications
Balchem is part of several thematic ideas from Synthetics to Chemicals Makers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Balchem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Balchem's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Balchem growth as a starting point in their analysis.
Price Earnings To Growth Ratio
1.58
At present, Balchem's Price Earnings To Growth Ratio is projected to slightly grow based on the last few years of reporting.
Balchem July 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Balchem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Balchem. We use our internally-developed statistical techniques to arrive at the intrinsic value of Balchem based on widely used predictive technical indicators. In general, we focus on analyzing Balchem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Balchem's daily price indicators and compare them against related drivers.
When running Balchem's price analysis, check to measure Balchem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balchem is operating at the current time. Most of Balchem's value examination focuses on studying past and present price action to predict the probability of Balchem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balchem's price. Additionally, you may evaluate how the addition of Balchem to your portfolios can decrease your overall portfolio volatility.